Rank | Gene Set | Z-score |
---|---|---|
1 | axon ensheathment in central nervous system (GO:0032291) | 7.48418776 |
2 | central nervous system myelination (GO:0022010) | 7.48418776 |
3 | ribosomal small subunit assembly (GO:0000028) | 6.50535043 |
4 | protein localization to endoplasmic reticulum (GO:0070972) | 5.57690577 |
5 | ensheathment of neurons (GO:0007272) | 5.20992302 |
6 | axon ensheathment (GO:0008366) | 5.20992302 |
7 | modulation by virus of host process (GO:0019054) | 5.18581310 |
8 | myelination (GO:0042552) | 5.08012580 |
9 | modulation by symbiont of host cellular process (GO:0044068) | 4.68063819 |
10 | macromolecular complex disassembly (GO:0032984) | 4.61247004 |
11 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.54474764 |
12 | protein targeting to membrane (GO:0006612) | 4.31284752 |
13 | nuclear envelope reassembly (GO:0031468) | 4.24489367 |
14 | mitotic nuclear envelope reassembly (GO:0007084) | 4.24489367 |
15 | maturation of SSU-rRNA (GO:0030490) | 4.24323129 |
16 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.19423265 |
17 | establishment of apical/basal cell polarity (GO:0035089) | 4.16366902 |
18 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 4.14993714 |
19 | establishment of mitochondrion localization (GO:0051654) | 4.13685105 |
20 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.02944564 |
21 | myelin maintenance (GO:0043217) | 3.87637913 |
22 | polarized epithelial cell differentiation (GO:0030859) | 3.86855466 |
23 | apoptotic process involved in morphogenesis (GO:0060561) | 3.86657182 |
24 | viral transcription (GO:0019083) | 3.85164329 |
25 | transcription from mitochondrial promoter (GO:0006390) | 3.82841581 |
26 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.80050734 |
27 | negative regulation of GTP catabolic process (GO:0033125) | 3.76666492 |
28 | negative regulation of GTPase activity (GO:0034260) | 3.76666492 |
29 | formation of translation preinitiation complex (GO:0001731) | 3.73064287 |
30 | GDP-mannose metabolic process (GO:0019673) | 3.71603897 |
31 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.70339748 |
32 | astrocyte development (GO:0014002) | 3.69511320 |
33 | negative regulation of viral release from host cell (GO:1902187) | 3.68107856 |
34 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.67760459 |
35 | protein maturation by protein folding (GO:0022417) | 3.65059540 |
36 | ribosomal small subunit biogenesis (GO:0042274) | 3.64667766 |
37 | negative regulation of Ras GTPase activity (GO:0034261) | 3.63859225 |
38 | translational termination (GO:0006415) | 3.60593432 |
39 | translation (GO:0006412) | 3.59013703 |
40 | cell migration in hindbrain (GO:0021535) | 3.58140729 |
41 | mRNA catabolic process (GO:0006402) | 3.51689611 |
42 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.48428034 |
43 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.48420475 |
44 | establishment of monopolar cell polarity (GO:0061162) | 3.48420475 |
45 | histone arginine methylation (GO:0034969) | 3.43506896 |
46 | amyloid precursor protein catabolic process (GO:0042987) | 3.42528687 |
47 | protein neddylation (GO:0045116) | 3.42323606 |
48 | ncRNA 3-end processing (GO:0043628) | 3.40569380 |
49 | DNA deamination (GO:0045006) | 3.32907850 |
50 | regulation of gene silencing by RNA (GO:0060966) | 3.32183445 |
51 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.32183445 |
52 | regulation of gene silencing by miRNA (GO:0060964) | 3.32183445 |
53 | modulation by virus of host morphology or physiology (GO:0019048) | 3.27837406 |
54 | negative regulation of nucleotide catabolic process (GO:0030812) | 3.27786667 |
55 | RNA catabolic process (GO:0006401) | 3.23490779 |
56 | negative regulation of JAK-STAT cascade (GO:0046426) | 3.22433292 |
57 | fatty acid elongation (GO:0030497) | 3.19576647 |
58 | enteric nervous system development (GO:0048484) | 3.16800935 |
59 | protein localization to endosome (GO:0036010) | 3.16141978 |
60 | translational initiation (GO:0006413) | 3.14673190 |
61 | apoptotic process involved in development (GO:1902742) | 3.14409693 |
62 | pentose metabolic process (GO:0019321) | 3.12666955 |
63 | establishment of protein localization to membrane (GO:0090150) | 3.12239721 |
64 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.10625036 |
65 | actin nucleation (GO:0045010) | 3.09794526 |
66 | heterochromatin organization (GO:0070828) | 3.09281614 |
67 | negative regulation of purine nucleotide catabolic process (GO:0033122) | 3.08868680 |
68 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.08638635 |
69 | regulation of response to osmotic stress (GO:0047484) | 3.06881564 |
70 | pyrimidine nucleoside salvage (GO:0043097) | 3.05632157 |
71 | pyrimidine-containing compound salvage (GO:0008655) | 3.05632157 |
72 | myelination in peripheral nervous system (GO:0022011) | 3.05522927 |
73 | peripheral nervous system axon ensheathment (GO:0032292) | 3.05522927 |
74 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.04730928 |
75 | mitochondrion transport along microtubule (GO:0047497) | 3.04730928 |
76 | translational elongation (GO:0006414) | 3.04288186 |
77 | maternal placenta development (GO:0001893) | 3.04232310 |
78 | UV protection (GO:0009650) | 3.04018454 |
79 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 3.03549055 |
80 | pentose-phosphate shunt (GO:0006098) | 3.02681703 |
81 | NIK/NF-kappaB signaling (GO:0038061) | 3.02644256 |
82 | ATP synthesis coupled proton transport (GO:0015986) | 3.01412795 |
83 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.01412795 |
84 | creatine metabolic process (GO:0006600) | 2.98736842 |
85 | detection of temperature stimulus (GO:0016048) | 2.97147996 |
86 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.94791597 |
87 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.92735483 |
88 | ribosomal large subunit biogenesis (GO:0042273) | 2.92114621 |
89 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.92023127 |
90 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.92023127 |
91 | regulation of viral release from host cell (GO:1902186) | 2.90822581 |
92 | regulation of early endosome to late endosome transport (GO:2000641) | 2.90523994 |
93 | negative regulation of adherens junction organization (GO:1903392) | 2.88418277 |
94 | negative regulation of focal adhesion assembly (GO:0051895) | 2.88418277 |
95 | negative regulation of cell junction assembly (GO:1901889) | 2.88418277 |
96 | cellular protein complex disassembly (GO:0043624) | 2.87582765 |
97 | membrane tubulation (GO:0097320) | 2.86478255 |
98 | asymmetric protein localization (GO:0008105) | 2.85896457 |
99 | viral life cycle (GO:0019058) | 2.85650005 |
100 | regulation of collateral sprouting (GO:0048670) | 2.84836468 |
101 | mitochondrial DNA metabolic process (GO:0032042) | 2.83112577 |
102 | peptidyl-arginine N-methylation (GO:0035246) | 2.82728101 |
103 | peptidyl-arginine methylation (GO:0018216) | 2.82728101 |
104 | proline biosynthetic process (GO:0006561) | 2.81095326 |
105 | aerobic respiration (GO:0009060) | 2.78979065 |
106 | oxidative phosphorylation (GO:0006119) | 2.77157914 |
107 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.76676655 |
108 | amino acid import (GO:0043090) | 2.76170315 |
109 | protein targeting to ER (GO:0045047) | 2.73481820 |
110 | activation of MAPKKK activity (GO:0000185) | 2.72967607 |
111 | L-serine metabolic process (GO:0006563) | 2.72313639 |
112 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.70735274 |
113 | cotranslational protein targeting to membrane (GO:0006613) | 2.70132773 |
114 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.68934785 |
115 | response to peptidoglycan (GO:0032494) | 2.68916503 |
116 | adhesion of symbiont to host cell (GO:0044650) | 2.68831379 |
117 | virion attachment to host cell (GO:0019062) | 2.68831379 |
118 | oligodendrocyte differentiation (GO:0048709) | 2.68805980 |
119 | mitochondrial calcium ion transport (GO:0006851) | 2.67668819 |
120 | cellular component biogenesis (GO:0044085) | 2.67259637 |
121 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.66942822 |
122 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.66634440 |
123 | regulation of translational fidelity (GO:0006450) | 2.66455191 |
124 | regulation of translational elongation (GO:0006448) | 2.66332916 |
125 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.64446972 |
126 | protein targeting (GO:0006605) | 2.64110602 |
127 | COPI coating of Golgi vesicle (GO:0048205) | 2.63283202 |
128 | Golgi transport vesicle coating (GO:0048200) | 2.63283202 |
129 | barbed-end actin filament capping (GO:0051016) | 2.62894855 |
130 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.62082577 |
131 | negative regulation of macroautophagy (GO:0016242) | 2.59937727 |
132 | establishment of mitotic spindle localization (GO:0040001) | 2.59912611 |
133 | rRNA processing (GO:0006364) | 2.59402624 |
134 | spinal cord development (GO:0021510) | 2.58441582 |
135 | establishment or maintenance of bipolar cell polarity (GO:0061245) | 2.58280924 |
136 | establishment or maintenance of apical/basal cell polarity (GO:0035088) | 2.58280924 |
137 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.57322647 |
138 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.57260326 |
139 | pseudouridine synthesis (GO:0001522) | 2.56738540 |
140 | neurotransmitter uptake (GO:0001504) | 2.56421180 |
141 | positive regulation of developmental pigmentation (GO:0048087) | 2.55555184 |
142 | regulation of translational termination (GO:0006449) | 2.54393459 |
143 | protein complex disassembly (GO:0043241) | 2.53722270 |
144 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.53433312 |
145 | regulation of hippo signaling (GO:0035330) | 2.53307210 |
146 | mitochondrial fusion (GO:0008053) | 2.52735287 |
147 | protein retention in ER lumen (GO:0006621) | 2.52732521 |
148 | short-term memory (GO:0007614) | 2.52687687 |
149 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.52604734 |
150 | NADPH regeneration (GO:0006740) | 2.48108872 |
151 | neutrophil activation involved in immune response (GO:0002283) | 2.46997922 |
152 | microtubule severing (GO:0051013) | 2.45228049 |
153 | protein localization to membrane (GO:0072657) | 2.42404559 |
154 | ribosome biogenesis (GO:0042254) | 2.40976610 |
155 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.40282667 |
156 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.39554288 |
157 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.39552045 |
158 | heme biosynthetic process (GO:0006783) | 2.38476844 |
159 | rRNA modification (GO:0000154) | 2.38382606 |
160 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.37781375 |
161 | respiratory electron transport chain (GO:0022904) | 2.37587675 |
162 | myeloid cell homeostasis (GO:0002262) | 2.34966932 |
163 | glucose catabolic process (GO:0006007) | 2.34078825 |
164 | folic acid metabolic process (GO:0046655) | 2.33246876 |
165 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.32366686 |
166 | negative regulation of cell size (GO:0045792) | 2.30916193 |
167 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.30840699 |
168 | negative regulation of phagocytosis (GO:0050765) | 2.30282127 |
169 | NADH metabolic process (GO:0006734) | 2.29261387 |
170 | protein insertion into membrane (GO:0051205) | 2.28485740 |
171 | electron transport chain (GO:0022900) | 2.27425251 |
172 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.27278533 |
173 | histone H2B ubiquitination (GO:0033523) | 2.26761956 |
174 | protein targeting to mitochondrion (GO:0006626) | 2.26556709 |
175 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.26339640 |
176 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.25778714 |
177 | T cell apoptotic process (GO:0070231) | 2.25747543 |
Rank | Gene Set | Z-score |
---|---|---|
1 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.90495179 |
2 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.90495179 |
3 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.90495179 |
4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.39249866 |
5 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.04864834 |
6 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.84768421 |
7 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.51547356 |
8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.46583118 |
9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.38280493 |
10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.29915149 |
11 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.27304552 |
12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.23377901 |
13 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.21252773 |
14 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 2.18109832 |
15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.13153644 |
16 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.04363563 |
17 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.96357540 |
18 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.92714016 |
19 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.91626285 |
20 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.90995728 |
21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.89963248 |
22 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.86880450 |
23 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.86778446 |
24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.86366916 |
25 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.85870817 |
26 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.85435554 |
27 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.84402582 |
28 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.83640930 |
29 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.82499650 |
30 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.78152915 |
31 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.67710393 |
32 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.65756579 |
33 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.65301185 |
34 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.65225504 |
35 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.63662502 |
36 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.63560357 |
37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.63390526 |
38 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.59332966 |
39 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.58693245 |
40 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.58658810 |
41 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57204367 |
42 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.56531638 |
43 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.55453009 |
44 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.54764044 |
45 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.53480916 |
46 | * YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.52098547 |
47 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.51623908 |
48 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.51014224 |
49 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.50302356 |
50 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.49009730 |
51 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.48053461 |
52 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.47919264 |
53 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.45287151 |
54 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.45076531 |
55 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.44319149 |
56 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.44162293 |
57 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.43835726 |
58 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.40615781 |
59 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.38104464 |
60 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.37460515 |
61 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.37400835 |
62 | MYC_22102868_ChIP-Seq_BL_Human | 1.37164314 |
63 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.37082603 |
64 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.36566281 |
65 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.35978272 |
66 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.34505085 |
67 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.34163583 |
68 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33589681 |
69 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.32655138 |
70 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.31606050 |
71 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.31450152 |
72 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.31340105 |
73 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.31113174 |
74 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.30880298 |
75 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.29671178 |
76 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.29319929 |
77 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.28102171 |
78 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.27979854 |
79 | MAF_26560356_Chip-Seq_TH1_Human | 1.27623195 |
80 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.27297129 |
81 | UTX_26944678_Chip-Seq_JUKART_Human | 1.26392736 |
82 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.26179889 |
83 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.25903073 |
84 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.25675459 |
85 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.24834638 |
86 | * P68_20966046_ChIP-Seq_HELA_Human | 1.24270325 |
87 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.24102073 |
88 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.23708750 |
89 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.23224065 |
90 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.23181371 |
91 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.23172077 |
92 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.22689874 |
93 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.22509155 |
94 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.21788272 |
95 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21509678 |
96 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.21208113 |
97 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.20725177 |
98 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.19627396 |
99 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.18908868 |
100 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.18448438 |
101 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.18391083 |
102 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.18197882 |
103 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18106205 |
104 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.17821113 |
105 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.17197828 |
106 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.16956739 |
107 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.15949553 |
108 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.15922672 |
109 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.14764120 |
110 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.14653847 |
111 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.13149348 |
112 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.12469344 |
113 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.12199685 |
114 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.12161093 |
115 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11131434 |
116 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09378280 |
117 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.09045140 |
118 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.07456067 |
119 | KDM2B_26808549_Chip-Seq_K562_Human | 1.07417689 |
120 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.07030415 |
121 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.06606688 |
122 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.06103627 |
123 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.05863584 |
124 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.05540433 |
125 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.05487864 |
126 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.05368381 |
127 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.04773712 |
128 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.04400654 |
129 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.04264723 |
130 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.04160877 |
131 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.03720673 |
132 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.02758178 |
133 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02751857 |
134 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.01742911 |
135 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.01198898 |
136 | MAF_26560356_Chip-Seq_TH2_Human | 1.00905785 |
137 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00104657 |
138 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.99856301 |
139 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.99792297 |
140 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99365043 |
141 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.98181774 |
142 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.96731694 |
143 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.95791063 |
144 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.95450379 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0009379_abnormal_foot_pigmentation | 4.49422312 |
2 | MP0003136_yellow_coat_color | 3.41467929 |
3 | MP0000920_abnormal_myelination | 3.00222930 |
4 | MP0003436_decreased_susceptibility_to | 2.95464036 |
5 | MP0002653_abnormal_ependyma_morphology | 2.82177739 |
6 | MP0009333_abnormal_splenocyte_physiolog | 2.63819425 |
7 | MP0010030_abnormal_orbit_morphology | 2.59050919 |
8 | MP0005451_abnormal_body_composition | 2.46094025 |
9 | MP0005171_absent_coat_pigmentation | 2.41041815 |
10 | MP0008057_abnormal_DNA_replication | 2.39935745 |
11 | MP0005623_abnormal_meninges_morphology | 2.36831791 |
12 | MP0004185_abnormal_adipocyte_glucose | 2.18657801 |
13 | MP0002877_abnormal_melanocyte_morpholog | 2.03145136 |
14 | MP0009840_abnormal_foam_cell | 2.02910254 |
15 | MP0005671_abnormal_response_to | 1.95997736 |
16 | MP0004133_heterotaxia | 1.89837289 |
17 | MP0001849_ear_inflammation | 1.89428896 |
18 | MP0003283_abnormal_digestive_organ | 1.87637522 |
19 | MP0000762_abnormal_tongue_morphology | 1.85921335 |
20 | MP0008932_abnormal_embryonic_tissue | 1.85070235 |
21 | MP0003705_abnormal_hypodermis_morpholog | 1.80449576 |
22 | MP0000343_altered_response_to | 1.80221719 |
23 | MP0003634_abnormal_glial_cell | 1.79868492 |
24 | MP0004142_abnormal_muscle_tone | 1.75377945 |
25 | MP0003806_abnormal_nucleotide_metabolis | 1.71714220 |
26 | MP0000604_amyloidosis | 1.70321139 |
27 | MP0003950_abnormal_plasma_membrane | 1.62334250 |
28 | MP0004145_abnormal_muscle_electrophysio | 1.60917408 |
29 | MP0004742_abnormal_vestibular_system | 1.60073002 |
30 | MP0004957_abnormal_blastocyst_morpholog | 1.59472386 |
31 | MP0003938_abnormal_ear_development | 1.59147395 |
32 | MP0009278_abnormal_bone_marrow | 1.57545638 |
33 | MP0000747_muscle_weakness | 1.54251858 |
34 | MP0000490_abnormal_crypts_of | 1.53279949 |
35 | MP0000462_abnormal_digestive_system | 1.51858081 |
36 | MP0002148_abnormal_hypersensitivity_rea | 1.51704629 |
37 | MP0004885_abnormal_endolymph | 1.51395672 |
38 | MP0003075_altered_response_to | 1.50148308 |
39 | MP0005330_cardiomyopathy | 1.49792718 |
40 | MP0005025_abnormal_response_to | 1.49341416 |
41 | MP0000778_abnormal_nervous_system | 1.49053421 |
42 | MP0000733_abnormal_muscle_development | 1.45938452 |
43 | MP0002089_abnormal_postnatal_growth/wei | 1.45623974 |
44 | MP0006036_abnormal_mitochondrial_physio | 1.45159878 |
45 | MP0001533_abnormal_skeleton_physiology | 1.45101690 |
46 | MP0004233_abnormal_muscle_weight | 1.44196017 |
47 | MP0000858_altered_metastatic_potential | 1.42580195 |
48 | MP0001881_abnormal_mammary_gland | 1.40792544 |
49 | MP0003303_peritoneal_inflammation | 1.40557244 |
50 | MP0003186_abnormal_redox_activity | 1.40440920 |
51 | MP0008438_abnormal_cutaneous_collagen | 1.40382808 |
52 | MP0001348_abnormal_lacrimal_gland | 1.40131251 |
53 | MP0001730_embryonic_growth_arrest | 1.39990117 |
54 | MP0000467_abnormal_esophagus_morphology | 1.39621257 |
55 | MP0002085_abnormal_embryonic_tissue | 1.38360310 |
56 | MP0000955_abnormal_spinal_cord | 1.33697471 |
57 | MP0005000_abnormal_immune_tolerance | 1.33351087 |
58 | MP0005464_abnormal_platelet_physiology | 1.30848475 |
59 | MP0002733_abnormal_thermal_nociception | 1.30379524 |
60 | MP0001485_abnormal_pinna_reflex | 1.30118841 |
61 | MP0002163_abnormal_gland_morphology | 1.29795928 |
62 | MP0005387_immune_system_phenotype | 1.28483622 |
63 | MP0001790_abnormal_immune_system | 1.28483622 |
64 | MP0002111_abnormal_tail_morphology | 1.27820883 |
65 | MP0002419_abnormal_innate_immunity | 1.27137645 |
66 | MP0001293_anophthalmia | 1.27014378 |
67 | MP0005058_abnormal_lysosome_morphology | 1.26785563 |
68 | MP0000685_abnormal_immune_system | 1.24901850 |
69 | MP0000428_abnormal_craniofacial_morphol | 1.23580691 |
70 | MP0002084_abnormal_developmental_patter | 1.17794752 |
71 | MP0003119_abnormal_digestive_system | 1.17525989 |
72 | MP0002132_abnormal_respiratory_system | 1.17425771 |
73 | MP0003137_abnormal_impulse_conducting | 1.17418360 |
74 | MP0001853_heart_inflammation | 1.16909457 |
75 | MP0004947_skin_inflammation | 1.16409392 |
76 | MP0005666_abnormal_adipose_tissue | 1.16196218 |
77 | MP0003755_abnormal_palate_morphology | 1.16001062 |
78 | MP0004858_abnormal_nervous_system | 1.15584904 |
79 | MP0003111_abnormal_nucleus_morphology | 1.14556038 |
80 | MP0000383_abnormal_hair_follicle | 1.14428269 |
81 | MP0003172_abnormal_lysosome_physiology | 1.13924437 |
82 | MP0006035_abnormal_mitochondrial_morpho | 1.13397782 |
83 | MP0003385_abnormal_body_wall | 1.12484361 |
84 | MP0003329_amyloid_beta_deposits | 1.12455139 |
85 | MP0005670_abnormal_white_adipose | 1.12438847 |
86 | MP0002751_abnormal_autonomic_nervous | 1.12091901 |
87 | MP0004381_abnormal_hair_follicle | 1.11409102 |
88 | MP0003123_paternal_imprinting | 1.10230474 |
89 | MP0002723_abnormal_immune_serum | 1.10113126 |
90 | MP0003221_abnormal_cardiomyocyte_apopto | 1.09697407 |
91 | MP0003453_abnormal_keratinocyte_physiol | 1.09374553 |
92 | MP0003690_abnormal_glial_cell | 1.09086235 |
93 | MP0005394_taste/olfaction_phenotype | 1.09037073 |
94 | MP0005499_abnormal_olfactory_system | 1.09037073 |
95 | MP0005380_embryogenesis_phenotype | 1.08769542 |
96 | MP0001672_abnormal_embryogenesis/_devel | 1.08769542 |
97 | MP0000015_abnormal_ear_pigmentation | 1.08763018 |
98 | MP0002998_abnormal_bone_remodeling | 1.08716913 |
99 | MP0001819_abnormal_immune_cell | 1.08001322 |
100 | MP0002420_abnormal_adaptive_immunity | 1.07369685 |
101 | MP0002064_seizures | 1.06517014 |
102 | MP0003937_abnormal_limbs/digits/tail_de | 1.06260166 |
103 | MP0009785_altered_susceptibility_to | 1.06022980 |
104 | MP0003763_abnormal_thymus_physiology | 1.05519372 |
105 | MP0005360_urolithiasis | 1.04781862 |
106 | MP0000759_abnormal_skeletal_muscle | 1.04444243 |
107 | MP0003861_abnormal_nervous_system | 1.04075750 |
108 | MP0005257_abnormal_intraocular_pressure | 1.03825731 |
109 | MP0008260_abnormal_autophagy | 1.03586829 |
110 | MP0002452_abnormal_antigen_presenting | 1.02741408 |
111 | MP0001697_abnormal_embryo_size | 1.01703292 |
112 | MP0002229_neurodegeneration | 1.01371850 |
113 | MP0002932_abnormal_joint_morphology | 1.00594687 |
114 | MP0004270_analgesia | 1.00561322 |
115 | MP0001970_abnormal_pain_threshold | 1.00356722 |
116 | MP0002114_abnormal_axial_skeleton | 1.00047255 |
117 | MP0002882_abnormal_neuron_morphology | 0.99677029 |
118 | MP0000751_myopathy | 0.99361822 |
119 | MP0000350_abnormal_cell_proliferation | 0.98550631 |
120 | MP0000750_abnormal_muscle_regeneration | 0.98414129 |
121 | MP0002272_abnormal_nervous_system | 0.97160931 |
122 | MP0005075_abnormal_melanosome_morpholog | 0.97087215 |
123 | MP0000678_abnormal_parathyroid_gland | 0.97076128 |
124 | MP0003632_abnormal_nervous_system | 0.96924374 |
125 | MP0002269_muscular_atrophy | 0.96729839 |
126 | MP0002752_abnormal_somatic_nervous | 0.95856068 |
127 | MP0008789_abnormal_olfactory_epithelium | 0.95006961 |
128 | MP0002429_abnormal_blood_cell | 0.94771949 |
129 | MP0002080_prenatal_lethality | 0.94695573 |
130 | MP0000749_muscle_degeneration | 0.93987243 |
131 | MP0002398_abnormal_bone_marrow | 0.93612389 |
132 | MP0000579_abnormal_nail_morphology | 0.93311347 |
133 | MP0005023_abnormal_wound_healing | 0.93284131 |
134 | MP0009250_abnormal_appendicular_skeleto | 0.93107598 |
135 | MP0005397_hematopoietic_system_phenotyp | 0.92523364 |
136 | MP0001545_abnormal_hematopoietic_system | 0.92523364 |
137 | MP0005390_skeleton_phenotype | 0.92044812 |
138 | MP0004197_abnormal_fetal_growth/weight/ | 0.91922397 |
139 | MP0005375_adipose_tissue_phenotype | 0.91408278 |
140 | MP0010307_abnormal_tumor_latency | 0.90875026 |
141 | MP0005501_abnormal_skin_physiology | 0.90208404 |
142 | MP0002066_abnormal_motor_capabilities/c | 0.89694311 |
143 | MP0001529_abnormal_vocalization | 0.89494818 |
144 | MP0000537_abnormal_urethra_morphology | 0.88797100 |
145 | MP0005508_abnormal_skeleton_morphology | 0.88702369 |
146 | MP0002092_abnormal_eye_morphology | 0.88563492 |
147 | MP0000534_abnormal_ureter_morphology | 0.88393285 |
148 | MP0002249_abnormal_larynx_morphology | 0.87773186 |
149 | MP0002796_impaired_skin_barrier | 0.86330766 |
150 | MP0000716_abnormal_immune_system | 0.86233823 |
151 | MP0002152_abnormal_brain_morphology | 0.86219375 |
152 | MP0001727_abnormal_embryo_implantation | 0.85841429 |
153 | MP0010678_abnormal_skin_adnexa | 0.84221959 |
154 | MP0003077_abnormal_cell_cycle | 0.84018612 |
155 | MP0003935_abnormal_craniofacial_develop | 0.83662044 |
156 | MP0001835_abnormal_antigen_presentation | 0.83323020 |
157 | MP0000681_abnormal_thyroid_gland | 0.82193322 |
158 | MP0008469_abnormal_protein_level | 0.82040142 |
159 | MP0003984_embryonic_growth_retardation | 0.81856382 |
160 | MP0009053_abnormal_anal_canal | 0.81784501 |
161 | MP0003191_abnormal_cellular_cholesterol | 0.81692687 |
162 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.81519712 |
163 | MP0003693_abnormal_embryo_hatching | 0.80774550 |
164 | MP0002088_abnormal_embryonic_growth/wei | 0.80491736 |
165 | MP0005319_abnormal_enzyme/_coenzyme | 0.80280790 |
166 | MP0001340_abnormal_eyelid_morphology | 0.80263750 |
167 | MP0002116_abnormal_craniofacial_bone | 0.80130004 |
168 | MP0003300_gastrointestinal_ulcer | 0.78730417 |
169 | MP0001915_intracranial_hemorrhage | 0.78350024 |
170 | MP0001845_abnormal_inflammatory_respons | 0.77937863 |
171 | MP0000313_abnormal_cell_death | 0.76289157 |
172 | MP0001800_abnormal_humoral_immune | 0.75715657 |
173 | MP0002722_abnormal_immune_system | 0.75414226 |
174 | MP0003448_altered_tumor_morphology | 0.74945320 |
175 | MP0004510_myositis | 0.74046049 |
176 | MP0001663_abnormal_digestive_system | 0.72730469 |
177 | MP0000003_abnormal_adipose_tissue | 0.72432907 |
178 | MP0001186_pigmentation_phenotype | 0.72263986 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Cerebral hypomyelination (HP:0006808) | 5.68024831 |
2 | Concave nail (HP:0001598) | 5.14087215 |
3 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 4.41010273 |
4 | Axonal loss (HP:0003447) | 4.14923713 |
5 | Sensory axonal neuropathy (HP:0003390) | 4.07845631 |
6 | Vertebral compression fractures (HP:0002953) | 4.06271013 |
7 | Ragged-red muscle fibers (HP:0003200) | 3.67052018 |
8 | Premature rupture of membranes (HP:0001788) | 3.66077338 |
9 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.55889459 |
10 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.55889459 |
11 | Reticulocytopenia (HP:0001896) | 3.49415324 |
12 | Rib fusion (HP:0000902) | 3.43996676 |
13 | Hypertensive crisis (HP:0100735) | 3.41540894 |
14 | Progressive external ophthalmoplegia (HP:0000590) | 3.40559252 |
15 | Distal lower limb muscle weakness (HP:0009053) | 3.37676621 |
16 | Upper motor neuron abnormality (HP:0002127) | 3.29203706 |
17 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.23062496 |
18 | Achilles tendon contracture (HP:0001771) | 3.22849811 |
19 | Coronal craniosynostosis (HP:0004440) | 3.20654351 |
20 | Premature skin wrinkling (HP:0100678) | 3.15611443 |
21 | Abnormality of the corticospinal tract (HP:0002492) | 3.15057904 |
22 | Alacrima (HP:0000522) | 3.09943300 |
23 | Ulnar bowing (HP:0003031) | 3.02385868 |
24 | Pallor (HP:0000980) | 3.01717513 |
25 | Myopathic facies (HP:0002058) | 3.00643167 |
26 | Severe visual impairment (HP:0001141) | 2.96920804 |
27 | Macrocytic anemia (HP:0001972) | 2.95758488 |
28 | Abnormal number of erythroid precursors (HP:0012131) | 2.93277019 |
29 | Hyperacusis (HP:0010780) | 2.91294653 |
30 | Distal lower limb amyotrophy (HP:0008944) | 2.90316017 |
31 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.81021952 |
32 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.81021952 |
33 | Neurofibrillary tangles (HP:0002185) | 2.79880625 |
34 | Abnormality of the Achilles tendon (HP:0005109) | 2.73752014 |
35 | Esophageal atresia (HP:0002032) | 2.71491206 |
36 | Turricephaly (HP:0000262) | 2.70950863 |
37 | Peripheral hypomyelination (HP:0007182) | 2.68346677 |
38 | Protrusio acetabuli (HP:0003179) | 2.65416011 |
39 | Rectal fistula (HP:0100590) | 2.63924792 |
40 | Rectovaginal fistula (HP:0000143) | 2.63924792 |
41 | Abnormal hemoglobin (HP:0011902) | 2.61654345 |
42 | Abnormality of the umbilical cord (HP:0010881) | 2.58022883 |
43 | CNS hypomyelination (HP:0003429) | 2.50299109 |
44 | Personality changes (HP:0000751) | 2.49297616 |
45 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.48914840 |
46 | Parakeratosis (HP:0001036) | 2.46143515 |
47 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.39637565 |
48 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.39637565 |
49 | Abnormality of glycolipid metabolism (HP:0010969) | 2.39637565 |
50 | Supranuclear gaze palsy (HP:0000605) | 2.39532117 |
51 | Astrocytoma (HP:0009592) | 2.38500043 |
52 | Abnormality of the astrocytes (HP:0100707) | 2.38500043 |
53 | Agnosia (HP:0010524) | 2.37655573 |
54 | Abnormality of reticulocytes (HP:0004312) | 2.37373587 |
55 | Large earlobe (HP:0009748) | 2.35522116 |
56 | Abnormality of the labia minora (HP:0012880) | 2.31153251 |
57 | Generalized amyotrophy (HP:0003700) | 2.28419510 |
58 | Progressive neurologic deterioration (HP:0002344) | 2.27894275 |
59 | Decreased lacrimation (HP:0000633) | 2.26913486 |
60 | Diaphragmatic weakness (HP:0009113) | 2.25157720 |
61 | Myokymia (HP:0002411) | 2.25025470 |
62 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.23859130 |
63 | Cerebral inclusion bodies (HP:0100314) | 2.23471158 |
64 | Absent radius (HP:0003974) | 2.23453266 |
65 | Absent septum pellucidum (HP:0001331) | 2.21488033 |
66 | Fused cervical vertebrae (HP:0002949) | 2.20482953 |
67 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.19659532 |
68 | Muscle fiber splitting (HP:0003555) | 2.18287357 |
69 | Long palpebral fissure (HP:0000637) | 2.18217312 |
70 | Absent forearm bone (HP:0003953) | 2.14253317 |
71 | Aplasia involving forearm bones (HP:0009822) | 2.14253317 |
72 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.13901534 |
73 | Clumsiness (HP:0002312) | 2.13663367 |
74 | Spastic gait (HP:0002064) | 2.13144326 |
75 | Insomnia (HP:0100785) | 2.12048158 |
76 | Progressive muscle weakness (HP:0003323) | 2.11801631 |
77 | Hypoplastic pelvis (HP:0008839) | 2.11588100 |
78 | Round ear (HP:0100830) | 2.10771032 |
79 | Neck muscle weakness (HP:0000467) | 2.10513250 |
80 | Anteriorly placed anus (HP:0001545) | 2.10448555 |
81 | Onion bulb formation (HP:0003383) | 2.10247689 |
82 | Increased muscle lipid content (HP:0009058) | 2.10143544 |
83 | Generalized hypotonia (HP:0001290) | 2.09945548 |
84 | Cholecystitis (HP:0001082) | 2.09619157 |
85 | Abnormal gallbladder physiology (HP:0012438) | 2.09619157 |
86 | Disinhibition (HP:0000734) | 2.09039124 |
87 | Septo-optic dysplasia (HP:0100842) | 2.06646474 |
88 | Vaginal fistula (HP:0004320) | 2.06316086 |
89 | Ependymoma (HP:0002888) | 2.05867008 |
90 | Difficulty climbing stairs (HP:0003551) | 2.05692297 |
91 | Abnormality of the septum pellucidum (HP:0007375) | 2.05460584 |
92 | Intestinal fistula (HP:0100819) | 2.05005827 |
93 | Rough bone trabeculation (HP:0100670) | 2.04959398 |
94 | Petechiae (HP:0000967) | 2.04958137 |
95 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.04015572 |
96 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.03799516 |
97 | Termporal pattern (HP:0011008) | 2.03600386 |
98 | Insidious onset (HP:0003587) | 2.03600386 |
99 | Increased intramyocellular lipid droplets (HP:0012240) | 2.03018049 |
100 | Purpura (HP:0000979) | 2.01574861 |
101 | Obstructive sleep apnea (HP:0002870) | 2.01559773 |
102 | Annular pancreas (HP:0001734) | 2.00829134 |
103 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.00193560 |
104 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.98853105 |
105 | Stridor (HP:0010307) | 1.98739566 |
106 | Trismus (HP:0000211) | 1.97398558 |
107 | Athetosis (HP:0002305) | 1.96758628 |
108 | Hypokinesia (HP:0002375) | 1.96504025 |
109 | Difficulty running (HP:0009046) | 1.95857036 |
110 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.94965857 |
111 | Hyporeflexia of lower limbs (HP:0002600) | 1.94791292 |
112 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.93896272 |
113 | Abnormality of the salivary glands (HP:0010286) | 1.92413995 |
114 | Single umbilical artery (HP:0001195) | 1.91833542 |
115 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.91833542 |
116 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.91833542 |
117 | Abnormal auditory evoked potentials (HP:0006958) | 1.90699238 |
118 | Vertebral fusion (HP:0002948) | 1.88846215 |
119 | Pathologic fracture (HP:0002756) | 1.88580658 |
120 | Increased connective tissue (HP:0009025) | 1.88436463 |
121 | Hepatosplenomegaly (HP:0001433) | 1.87911823 |
122 | Spinal rigidity (HP:0003306) | 1.86170768 |
123 | Opisthotonus (HP:0002179) | 1.84777205 |
124 | Aplasia of the musculature (HP:0100854) | 1.84631752 |
125 | Reticulocytosis (HP:0001923) | 1.84301185 |
126 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.84260536 |
127 | Dicarboxylic aciduria (HP:0003215) | 1.84260536 |
128 | Increased IgM level (HP:0003496) | 1.83265327 |
129 | Multiple enchondromatosis (HP:0005701) | 1.83176310 |
130 | Obstructive lung disease (HP:0006536) | 1.83060873 |
131 | Chronic obstructive pulmonary disease (HP:0006510) | 1.83060873 |
132 | Akinesia (HP:0002304) | 1.82238295 |
133 | Polygenic inheritance (HP:0010982) | 1.80888252 |
134 | Pterygium (HP:0001059) | 1.80459502 |
135 | Short humerus (HP:0005792) | 1.79455663 |
136 | Foot dorsiflexor weakness (HP:0009027) | 1.79094440 |
137 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.78543814 |
138 | Microvesicular hepatic steatosis (HP:0001414) | 1.78474209 |
139 | Broad face (HP:0000283) | 1.77800717 |
140 | Rhabdomyolysis (HP:0003201) | 1.76983555 |
141 | Biconcave vertebral bodies (HP:0004586) | 1.76434156 |
142 | Truncus arteriosus (HP:0001660) | 1.76251111 |
143 | Prominent occiput (HP:0000269) | 1.76015764 |
144 | Microretrognathia (HP:0000308) | 1.75887717 |
145 | Partial duplication of the phalanx of hand (HP:0009999) | 1.75445353 |
146 | Distal upper limb amyotrophy (HP:0007149) | 1.74585294 |
147 | Upper limb amyotrophy (HP:0009129) | 1.74585294 |
148 | Emotional lability (HP:0000712) | 1.73311784 |
149 | Abnormal number of incisors (HP:0011064) | 1.73292057 |
150 | Spastic paraparesis (HP:0002313) | 1.73054418 |
151 | Abnormal neuron morphology (HP:0012757) | 1.73004564 |
152 | Abnormality of the motor neurons (HP:0002450) | 1.73004564 |
153 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.72531978 |
154 | Breast hypoplasia (HP:0003187) | 1.70941428 |
155 | Bowel incontinence (HP:0002607) | 1.70908164 |
156 | Recurrent abscess formation (HP:0002722) | 1.70758080 |
157 | Adrenal hypoplasia (HP:0000835) | 1.70378435 |
158 | Cellulitis (HP:0100658) | 1.69916368 |
159 | Congenital hip dislocation (HP:0001374) | 1.69864789 |
160 | Neuronal loss in central nervous system (HP:0002529) | 1.69124137 |
161 | Vacuolated lymphocytes (HP:0001922) | 1.69062155 |
162 | J-shaped sella turcica (HP:0002680) | 1.69021537 |
163 | Partial agenesis of the corpus callosum (HP:0001338) | 1.68529805 |
164 | Hepatocellular necrosis (HP:0001404) | 1.68320504 |
165 | Recurrent bacterial skin infections (HP:0005406) | 1.67857054 |
166 | Ankle clonus (HP:0011448) | 1.67776910 |
167 | Testicular atrophy (HP:0000029) | 1.67768031 |
168 | Joint stiffness (HP:0001387) | 1.67211227 |
169 | Gastrointestinal stroma tumor (HP:0100723) | 1.67126900 |
170 | Abnormal large intestine physiology (HP:0012700) | 1.66832166 |
171 | Hyperthyroidism (HP:0000836) | 1.66469151 |
172 | Neoplasm of striated muscle (HP:0009728) | 1.66185091 |
173 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.66169063 |
174 | Dysostosis multiplex (HP:0000943) | 1.65747044 |
175 | Muscle fibrillation (HP:0010546) | 1.65606181 |
176 | Redundant skin (HP:0001582) | 1.65497088 |
177 | Relative macrocephaly (HP:0004482) | 1.65281922 |
178 | Bulbar palsy (HP:0001283) | 1.65190378 |
179 | Abnormal trabecular bone morphology (HP:0100671) | 1.65045213 |
180 | Seborrheic dermatitis (HP:0001051) | 1.64446957 |
181 | Broad distal phalanx of finger (HP:0009836) | 1.63627696 |
182 | Paraparesis (HP:0002385) | 1.63462948 |
183 | Abnormality of the foot musculature (HP:0001436) | 1.63234438 |
184 | Hepatic necrosis (HP:0002605) | 1.63009047 |
185 | Bone pain (HP:0002653) | 1.62903166 |
186 | Asplenia (HP:0001746) | 1.62766086 |
187 | Abnormality of macrophages (HP:0004311) | 1.61975080 |
188 | Deep palmar crease (HP:0006191) | 1.61491430 |
189 | Thrombocytosis (HP:0001894) | 1.61272100 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TLK1 | 4.59030171 |
2 | ICK | 3.74428183 |
3 | VRK2 | 3.63858623 |
4 | BCKDK | 3.57083253 |
5 | TYRO3 | 3.40313267 |
6 | SMG1 | 3.35588970 |
7 | STK39 | 3.30278631 |
8 | PRPF4B | 2.95353328 |
9 | UHMK1 | 2.80101714 |
10 | IRAK3 | 2.75085428 |
11 | DDR2 | 2.53755815 |
12 | ERN1 | 2.41283445 |
13 | TESK1 | 2.37432795 |
14 | NME1 | 2.20103381 |
15 | TESK2 | 2.19170046 |
16 | CDK19 | 2.12890262 |
17 | EPHB1 | 2.02377309 |
18 | BMX | 2.02214598 |
19 | SCYL2 | 1.99642514 |
20 | NME2 | 1.97869813 |
21 | OXSR1 | 1.94120656 |
22 | TAOK2 | 1.92904915 |
23 | FGR | 1.89814372 |
24 | LIMK1 | 1.76247865 |
25 | TRIB3 | 1.75573571 |
26 | ALK | 1.74526041 |
27 | BUB1 | 1.70012665 |
28 | MAP3K11 | 1.66371543 |
29 | CDK12 | 1.65317118 |
30 | SIK1 | 1.64946289 |
31 | MAP4K1 | 1.62383061 |
32 | PKN1 | 1.59183353 |
33 | PRKD2 | 1.57426866 |
34 | MARK2 | 1.46742765 |
35 | MET | 1.45032447 |
36 | EIF2AK1 | 1.44986621 |
37 | EEF2K | 1.44112794 |
38 | PHKG1 | 1.43237191 |
39 | PHKG2 | 1.43237191 |
40 | STK16 | 1.42741463 |
41 | DAPK3 | 1.38319431 |
42 | IRAK4 | 1.37715938 |
43 | ARAF | 1.37674018 |
44 | KDR | 1.32480947 |
45 | PINK1 | 1.30634432 |
46 | PIM2 | 1.29561001 |
47 | NTRK1 | 1.29391377 |
48 | WNK1 | 1.27799845 |
49 | PDGFRA | 1.24286018 |
50 | PAK6 | 1.22303562 |
51 | TBK1 | 1.21264400 |
52 | CSK | 1.19417813 |
53 | MAP2K3 | 1.15625064 |
54 | PAK4 | 1.15377012 |
55 | RPS6KB2 | 1.13786894 |
56 | WNK4 | 1.12829250 |
57 | LATS2 | 1.11793715 |
58 | ILK | 1.06206185 |
59 | CLK1 | 1.06173488 |
60 | ROCK2 | 1.03974576 |
61 | CDK7 | 1.03120298 |
62 | MAPKAPK3 | 1.01630250 |
63 | ABL2 | 0.96785704 |
64 | DMPK | 0.94632126 |
65 | MATK | 0.94457679 |
66 | GRK5 | 0.94277275 |
67 | CDK14 | 0.93497934 |
68 | PAK1 | 0.92511288 |
69 | MAP2K2 | 0.90581892 |
70 | MAPK15 | 0.89478837 |
71 | BRAF | 0.86979834 |
72 | CASK | 0.86600484 |
73 | EPHA2 | 0.82495027 |
74 | CDK15 | 0.80771274 |
75 | NEK1 | 0.80744098 |
76 | CDK11A | 0.79313488 |
77 | AURKA | 0.76966480 |
78 | DYRK1B | 0.76645527 |
79 | GSK3A | 0.76629330 |
80 | EPHB2 | 0.76183644 |
81 | PRKD1 | 0.72674436 |
82 | CAMK2B | 0.72221408 |
83 | PAK2 | 0.72220415 |
84 | PASK | 0.72133732 |
85 | SRPK1 | 0.71808425 |
86 | CDK18 | 0.69740619 |
87 | TTN | 0.69600123 |
88 | CSNK1G3 | 0.69122565 |
89 | FGFR2 | 0.68300234 |
90 | CDK8 | 0.67123716 |
91 | PTK6 | 0.66605517 |
92 | PKN2 | 0.66216841 |
93 | BRSK1 | 0.66047433 |
94 | TAOK1 | 0.63680394 |
95 | MAP3K1 | 0.61702207 |
96 | MOS | 0.60420918 |
97 | PDGFRB | 0.58876857 |
98 | HIPK2 | 0.58706417 |
99 | LMTK2 | 0.57942734 |
100 | CDK4 | 0.57684844 |
101 | CAMK2D | 0.57344582 |
102 | DAPK1 | 0.56692776 |
103 | MAPK11 | 0.56298732 |
104 | MKNK2 | 0.55256256 |
105 | FES | 0.54681454 |
106 | ZAP70 | 0.53121000 |
107 | MTOR | 0.52390377 |
108 | PRKG2 | 0.52149983 |
109 | DYRK2 | 0.51546142 |
110 | NEK2 | 0.51409278 |
111 | RIPK4 | 0.50961772 |
112 | CSNK1E | 0.50957410 |
113 | DYRK3 | 0.49837276 |
114 | FGFR4 | 0.48950157 |
115 | CAMK2G | 0.48861762 |
116 | PNCK | 0.47660064 |
117 | MAP3K10 | 0.47402000 |
118 | PDPK1 | 0.46691765 |
119 | CSNK1G1 | 0.46618796 |
120 | LRRK2 | 0.45973879 |
121 | MAPKAPK5 | 0.44554174 |
122 | IRAK2 | 0.44437418 |
123 | RPS6KA2 | 0.44235296 |
124 | MST4 | 0.43430498 |
125 | PLK1 | 0.43174258 |
126 | STK11 | 0.41593675 |
127 | MAP3K8 | 0.41050355 |
128 | TYK2 | 0.40332772 |
129 | CSNK1A1L | 0.38962987 |
130 | CSNK1D | 0.38657429 |
131 | CDK2 | 0.37925316 |
132 | CHEK2 | 0.37312536 |
133 | MAPKAPK2 | 0.37257483 |
134 | RPS6KL1 | 0.36237583 |
135 | RPS6KC1 | 0.36237583 |
136 | CSNK2A2 | 0.35717559 |
137 | IKBKB | 0.35651221 |
138 | GRK6 | 0.35566280 |
139 | INSR | 0.35172675 |
140 | CHEK1 | 0.34547333 |
141 | MAPK12 | 0.34128669 |
142 | MAPK10 | 0.33540308 |
143 | JAK3 | 0.33335092 |
144 | VRK1 | 0.32483697 |
145 | PRKCI | 0.31757772 |
146 | MAP3K6 | 0.31635550 |
147 | CAMKK1 | 0.31588121 |
148 | SYK | 0.31519458 |
149 | RPS6KA6 | 0.31081015 |
150 | CDC42BPA | 0.30776966 |
151 | AKT2 | 0.30236022 |
152 | CAMK2A | 0.29353347 |
153 | AURKB | 0.29235739 |
154 | RIPK1 | 0.28798651 |
155 | PBK | 0.28597592 |
156 | TTK | 0.27554162 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 3.93852102 |
2 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.92780859 |
3 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.35396550 |
4 | * Sulfur relay system_Homo sapiens_hsa04122 | 2.85981059 |
5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.82502856 |
6 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.73058082 |
7 | RNA polymerase_Homo sapiens_hsa03020 | 2.52608141 |
8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.43968709 |
9 | Spliceosome_Homo sapiens_hsa03040 | 2.26813865 |
10 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.98837140 |
11 | Mismatch repair_Homo sapiens_hsa03430 | 1.85902702 |
12 | RNA transport_Homo sapiens_hsa03013 | 1.83914959 |
13 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.75212834 |
14 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.68127995 |
15 | Base excision repair_Homo sapiens_hsa03410 | 1.67994981 |
16 | DNA replication_Homo sapiens_hsa03030 | 1.66477435 |
17 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.66118416 |
18 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.60408746 |
19 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.60164650 |
20 | Parkinsons disease_Homo sapiens_hsa05012 | 1.54936189 |
21 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.52536454 |
22 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.52394422 |
23 | Tight junction_Homo sapiens_hsa04530 | 1.50643932 |
24 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.48399043 |
25 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.46688004 |
26 | Axon guidance_Homo sapiens_hsa04360 | 1.46591550 |
27 | Bladder cancer_Homo sapiens_hsa05219 | 1.36607959 |
28 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.35932396 |
29 | Carbon metabolism_Homo sapiens_hsa01200 | 1.35925926 |
30 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.35266709 |
31 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.35194572 |
32 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.32751357 |
33 | Galactose metabolism_Homo sapiens_hsa00052 | 1.32432910 |
34 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.28473578 |
35 | Homologous recombination_Homo sapiens_hsa03440 | 1.27129854 |
36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.22422626 |
37 | Endocytosis_Homo sapiens_hsa04144 | 1.20335654 |
38 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.16041718 |
39 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.15741949 |
40 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.13615271 |
41 | Proteasome_Homo sapiens_hsa03050 | 1.12355589 |
42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.11754389 |
43 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.10521542 |
44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.10510785 |
45 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.09580963 |
46 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.08914152 |
47 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.08405216 |
48 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.07728764 |
49 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.07504988 |
50 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.06797273 |
51 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.04242486 |
52 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.03482896 |
53 | Prion diseases_Homo sapiens_hsa05020 | 0.99982259 |
54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.99016739 |
55 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.97887088 |
56 | Basal transcription factors_Homo sapiens_hsa03022 | 0.96160300 |
57 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.95168010 |
58 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91056299 |
59 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.89239432 |
60 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.88401959 |
61 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.87314052 |
62 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.87185873 |
63 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.86606084 |
64 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.84528252 |
65 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.81723966 |
66 | Huntingtons disease_Homo sapiens_hsa05016 | 0.81540449 |
67 | Alzheimers disease_Homo sapiens_hsa05010 | 0.81076651 |
68 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.80786986 |
69 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.79875680 |
70 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.79132845 |
71 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.79051712 |
72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.77620394 |
73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.76387909 |
74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.75849286 |
75 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.75773910 |
76 | Salmonella infection_Homo sapiens_hsa05132 | 0.75621750 |
77 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.75147982 |
78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.74358131 |
79 | Viral myocarditis_Homo sapiens_hsa05416 | 0.74027618 |
80 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.73657103 |
81 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.73410172 |
82 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73248037 |
83 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.72486617 |
84 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.72134746 |
85 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.70781277 |
86 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.69621502 |
87 | Leishmaniasis_Homo sapiens_hsa05140 | 0.69390166 |
88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69243208 |
89 | Cell cycle_Homo sapiens_hsa04110 | 0.68975023 |
90 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.68580679 |
91 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68124948 |
92 | Thyroid cancer_Homo sapiens_hsa05216 | 0.67321622 |
93 | Gap junction_Homo sapiens_hsa04540 | 0.67019367 |
94 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.67013841 |
95 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.65984230 |
96 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65973172 |
97 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.65593870 |
98 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65016652 |
99 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64950678 |
100 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.64360072 |
101 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.63665702 |
102 | Alcoholism_Homo sapiens_hsa05034 | 0.62600373 |
103 | Apoptosis_Homo sapiens_hsa04210 | 0.62545675 |
104 | Long-term depression_Homo sapiens_hsa04730 | 0.62027181 |
105 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.62001303 |
106 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61928961 |
107 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.61881273 |
108 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61402217 |
109 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60044644 |
110 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.58883539 |
111 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.58739375 |
112 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.58432979 |
113 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.58170139 |
114 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.58105513 |
115 | Purine metabolism_Homo sapiens_hsa00230 | 0.57626630 |
116 | Focal adhesion_Homo sapiens_hsa04510 | 0.55345606 |
117 | Lysosome_Homo sapiens_hsa04142 | 0.55305977 |
118 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.54379183 |
119 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.53837621 |
120 | Hepatitis C_Homo sapiens_hsa05160 | 0.53031658 |
121 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.52975965 |
122 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.52963276 |
123 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.52198191 |
124 | Influenza A_Homo sapiens_hsa05164 | 0.52100019 |
125 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.51735675 |
126 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51642561 |
127 | Pathways in cancer_Homo sapiens_hsa05200 | 0.51532563 |
128 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.50011749 |
129 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49950988 |
130 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.49762635 |
131 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48665060 |
132 | Shigellosis_Homo sapiens_hsa05131 | 0.46178988 |
133 | Hepatitis B_Homo sapiens_hsa05161 | 0.45232654 |
134 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.45133557 |
135 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.45031664 |
136 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.44911529 |
137 | Tuberculosis_Homo sapiens_hsa05152 | 0.44815846 |
138 | Glioma_Homo sapiens_hsa05214 | 0.44588407 |
139 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.44459923 |
140 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44276627 |
141 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43943295 |
142 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.43803709 |
143 | Allograft rejection_Homo sapiens_hsa05330 | 0.43466258 |
144 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.43126015 |
145 | Melanogenesis_Homo sapiens_hsa04916 | 0.42576734 |
146 | Measles_Homo sapiens_hsa05162 | 0.42034374 |
147 | Malaria_Homo sapiens_hsa05144 | 0.41217268 |
148 | Melanoma_Homo sapiens_hsa05218 | 0.39693355 |
149 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.39597413 |
150 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.39471261 |
151 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.39451374 |
152 | Pertussis_Homo sapiens_hsa05133 | 0.39164217 |
153 | Phagosome_Homo sapiens_hsa04145 | 0.38634675 |
154 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.37071721 |
155 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36091122 |
156 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.35547409 |
157 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.34782113 |